The Akums Drugs and Pharmaceuticals IPO is a combination of a fresh issue of 1 crore shares amounting to ₹680 crore and an offer for sale of 1.73 crore shares aggregating to ₹1,176.74 crores. The Akums IPO allotment status is set to be finalised today.

If you applied for the IPO, here is how you can check the Akums IPO allotment status.

Checking Allotment Status on Registrar's Website:

Follow these steps to check the Akums IPO allotment status

1. Visit the registrar's website.
2. Click on "Company Selection" and choose "Akums Drugs" from the dropdown menu.
3. Then you can enter your PAN, application number, or Demat.
4. Click Submit to retrieve the Akums IPO allotment status

Checking IPO Allotment Status on BSE:

1. Go to the BSE website.
2. Click on the ‘Equity' section and select "Akums Drugs from the dropdown menu.
3. Enter your application number or PAN.
4. Click on the ‘Search' button.
5. The result will show the number of shares allotted to you.

If all the details are entered correctly and the allotment has been finalised, the Akums IPO allotment status will be visible.

Akums Drugs And Pharmaceuticals IPO Subscription

The IPO opened for subscription on July 30 and closed on August 1. As of the closing date, the IPO had a subscription status of 63.56 times. The retail investor portion was subscribed 21.30 times, while the non-institutional investors (NII) portion saw an oversubscription of 42.21 times. The Qualified Institutional Buyers (QIBs) portion was subscribed 90.09 times.

See Also: Why This Us Hedge Fund Manager Is Not Impressed By Zomatos 253 Cr Profit

Akums Drugs And Pharmaceuticals IPO GMP

Akums IPO GMP is reported at ₹141. This indicates that the stock could list at ₹820, suggesting a 20% premium on the listing. However, it’s crucial to remember that while IPO GMPs can provide some insight into market sentiment towards an IPO, they should not be considered the sole factor determining the stock’s performance upon listing.

Akums Drugs And Pharmaceuticals IPO Details

The IPO price band was set at ₹646 to ₹679 per share, with a minimum lot size of 22 shares. Retail investors needed to invest a minimum of ₹14,938.

The net proceeds from the offering will be used for prepayment or scheduled repayment of existing borrowings, financing working capital requirements, pursuing growth through acquisitions, and addressing general corporate purposes.

About Akums Drugs And Pharmaceuticals

Established in 2004, Akums Drugs and Pharmaceuticals is a leading pharmaceutical contract development and manufacturing organisation (CDMO). It also manufactures and sells branded drugs and active pharmaceutical ingredients (APIs). For the year ended March 31, 2024, Akums reported a 13.81% increase in revenue. However, the company saw a 99.19% decline in profit after tax (PAT) compared to the previous year.

Read Next: Should You Invest In Ola Electric IPO?